Active surveillance in patients with a PSA >10 ng/mL

INTRODUCTION: The use of prostate-specific antigen (PSA) in active surveillance (AS) for prostate cancer is controversial. Some consider it an unreliable marker and others as sufficient evidence to exclude patients from AS. We analyzed our cohort of AS patients with a PSA over 10 ng/mL. METHODS: We...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Toren, Paul, Wong, Lih-Ming, Timilshina, Narhari, Alibhai, Shabbir, Trachtenberg, John, Fleshner, Neil, Finelli, Antonio
Formato: Artigo
Lenguaje:Inglês
Publicado: Canadian Medical Association 2014
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216302/
https://ncbi.nlm.nih.gov/pubmed/25408810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2121
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares